Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement.
BMJ
; 320(7233): 511-2, 2000 Feb 19.
Article
in En
| MEDLINE
| ID: mdl-10678874
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carbamates
/
Clinical Trials as Topic
/
Neuroprotective Agents
/
Phenylcarbamates
/
Alzheimer Disease
Limits:
Humans
Language:
En
Journal:
BMJ
Journal subject:
MEDICINA
Year:
2000
Document type:
Article